Search

Your search keyword '"De la Cueva-Dobao P"' showing total 27 results
Start Over Author "De la Cueva-Dobao P" Publisher elsevier bv
27 results on '"De la Cueva-Dobao P"'

1. [Translated article] Family Planning Concerns Among Women With Psoriasis: A Descriptive, Cross-Sectional, Multicenter Study

Author

Jiménez Gómez, N., primary, González-Cantero, Á., additional, Ruiz-Villaverde, R., additional, Llamas-Velasco, M., additional, de la Cueva Dobao, P., additional, Rivera Díaz, R., additional, Martínez Lorenzo, E., additional, Alonso Pacheco, M.L., additional, Baniandrés Rodríguez, O., additional, Mollet Sánchez, J., additional, Pitarch Bort, G., additional, Izu Belloso, R.M., additional, and Jaén Olasolo, P., additional

Published
2023
Full Text
View/download PDF

2. Percepción de la mujer con psoriasis en la planificación familiar: Estudio descriptivo, transversal y multicéntrico

Author

Jiménez Gómez, N., primary, González-Cantero, Á., additional, Ruiz-Villaverde, R., additional, Llamas-Velasco, M., additional, de la Cueva Dobao, P., additional, Rivera Díaz, R., additional, Martínez Lorenzo, E., additional, Alonso Pacheco, M.L., additional, Baniandrés Rodríguez, O., additional, Mollet Sánchez, J., additional, Pitarch Bort, G., additional, Izu Belloso, R.M., additional, and Jaén Olasolo, P., additional

Published
2023
Full Text
View/download PDF

3. [Translated article] Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer – Basal Cell Carcinoma or Squamous Cell Carcinoma – Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study

Author

Minano Medrano, R, Lopez Estebaranz, J L, Sanmartin-Jimenez, O, Garces, J R, Rodriguez-Prieto, M A, Vilarrasa-Rull, E, de Eusebio-Murillo, E, Escutia-Munoz, B, Florez-Menendez, A, Artola-Igarza, J L, Alfaro-Rubio, A, Redondo, P, Delgado-Jimenez, Y, Sanchez-Schmidt, J M, Allende-Markixana, I, Alonso-Pacheco, M L, Garcia-Bracamonte, B, de la Cueva-Dobao, P, Navarro-Tejedor, R, Ciudad-Blanco, C, Carnero-Gonzalez, L, Vazquez-Veiga, H, Cano-Martinez, N, Ruiz-Salas, V, Sanchez-Sambucety, P, Botella-Estrada, R, Gonzalez-Sixto, B, Martorell-Calatayud, A, Gil, P, Morales-Gordillo, V, Toll-Abello, A, Ocerin-Guerra, I, Mayor-Arenal, M, Suarez-Fernandez, R, Sainz-Gaspar, L, Descalzo, M A, and Garcia-Doval, I

Subjects
Carcinoma epidermoide cutáneo, Incidence, Carcinoma basocelular, General Medicine, Segunda neoplasia, Risk factors, Second cancer, Squamous cell carcinoma, Basal cell carcinoma, Cirugía micrográfica de Mohs, Incidencia, Mohs micrographic surgery, Factores de riesgo
Abstract

OBJECTIVE: Patients with nonmelanoma skin cancer (NMSC)-ie, basal cell carcinoma (BCC) or squamous cell carcinoma (SCC)-have an increased risk of developing a second skin cancer. The aim of this study was to describe the frequency, incidence per 1000 person-years, and predictors of a second skin cancer in a cohort of patients with NMSC treated with Mohs micrographic surgery (MMS). MATERIAL AND METHODS: Prospective study of a national cohort of patients with NMSC who underwent MMS at 22 Spanish hospitals between July 2013 and February 2020; case data were recorded in the REGESMOHS registry. The study variables included demographic characteristics, frequency and incidence per 1000 person-years of second skin cancers diagnosed during the study period, and risk factors identified using mixed-effects logistic regression. RESULTS: We analyzed data for 4768 patients who underwent MMS; 4397 (92%) had BCC and 371 (8%) had SCC. Mean follow-up was 2.4 years. Overall, 1201 patients (25%) developed a second skin cancer during follow-up; 1013 of the tumors were BCCs (21%), 154 were SCCs (3%), and 20 were melanomas (0.4%). The incidence was 107 per 1000 person-years (95% CI, 101-113) for any cancer, 90 per 1000 person-years (95% CI, 85-96) for BCC, 14 (95% CI, 12-16) per 1000 person-years for SCC, and 2 (95% CI, 1-3) per 1000 person-years for melanoma. More men than women developed a subsequent skin cancer (738 [61%] vs 463 [39%]). The main risk factors were a history of multiple tumors before diagnosis (relative risk [RR], 4.6; 95% CI, 2.9-7.1), immunosuppression (RR, 2.1; 95% CI, 1.4-3.1), and male sex (RR, 1.6; 95% CI, 1.4-1.9). CONCLUSION: Patients have an increased risk of developing a second tumor after MMS treatment of NMSC. Risk factors are a history of multiple tumors at diagnosis, immunosuppression, and male sex.

Published
2022

4. Riesgo de aparición de segundas neoplasias cutáneas en una cohorte de pacientes diagnosticados de carcinoma queratinocítico (carcinoma basocelular y carcinoma epidermoide) tratados con cirugía de Mohs. Estudio de cohortes prospectivo nacional

Author

Miñano Medrano, R., primary, López Estebaranz, J.L., additional, Sanmartin-Jiménez, O., additional, Garcés, J.R., additional, Rodríguez-Prieto, M.A., additional, Vilarrasa-Rull, E., additional, de Eusebio-Murillo, E., additional, Escutia-Muñoz, B., additional, Flórez-Menéndez, Á., additional, Artola-Igarza, J.L., additional, Alfaro-Rubio, A., additional, Redondo, P., additional, Delgado-Jiménez, Y., additional, Sánchez-Schmidt, J.M., additional, Allende-Markixana, I., additional, Alonso-Pacheco, M.L., additional, García-Bracamonte, B., additional, de la Cueva-Dobao, P., additional, Navarro-Tejedor, R., additional, Ciudad-Blanco, C., additional, Carnero-González, L., additional, Vázquez-Veiga, H., additional, Cano-Martínez, N., additional, Ruiz-Salas, V., additional, Sánchez-Sambucety, P., additional, Botella-Estrada, R., additional, González-Sixto, B., additional, Martorell-Calatayud, A., additional, Gil, P., additional, Morales-Gordillo, V., additional, Toll-Abelló, A., additional, Ocerin-Guerra, I., additional, Mayor-Arenal, M., additional, Suárez-Fernández, R., additional, Sainz-Gaspar, L., additional, Descalzo, M.A., additional, and García-Doval, I., additional

Published
2022
Full Text
View/download PDF

6. Validation of the Spanish Wound-QoL Questionnaire

Author

Conde Montero, E., primary, Sommer, R., additional, Augustin, M., additional, Blome, C., additional, Cabeza Martínez, R., additional, Horcajada Reales, C., additional, Alsina Gibert, M., additional, Ramón Sapena, R., additional, Peral Vázquez, A., additional, Montoro López, J., additional, Guisado Muñoz, S., additional, Pérez Jerónimo, L., additional, de la Cueva Dobao, P., additional, Kressel, N., additional, and Mohr, N., additional

Published
2021
Full Text
View/download PDF

7. Validación de la versión española del cuestionario Wound-QoL

Author

Conde Montero, E., primary, Sommer, R., additional, Augustin, M., additional, Blome, C., additional, Cabeza Martínez, R., additional, Horcajada Reales, C., additional, Alsina Gibert, M., additional, Ramón Sapena, R., additional, Peral Vázquez, A., additional, Montoro López, J., additional, Guisado Muñoz, S., additional, Pérez Jerónimo, L., additional, de la Cueva Dobao, P., additional, Kressel, N., additional, and Mohr, N., additional

Published
2021
Full Text
View/download PDF

17. Descripción de los pacientes que reciben biológicos como primer tratamiento sistémico en el registro BIOBADADERM durante el periodo 2008-2016

Author

Carretero Hernández, G., primary, Ferrándiz, C., additional, Rivera Díaz, R., additional, Daudén Tello, E., additional, de la Cueva-Dobao, P., additional, Gómez-García, F.J., additional, Herrera-Ceballos, E., additional, Belinchón Romero, I., additional, López-Estebaranz, J.L., additional, Alsina Gibert, M., additional, Sánchez-Carazo, J.L., additional, Ferrán Farrés, M., additional, González Quesada, A., additional, Carrascosa Carrillo, J.M., additional, Llamas-Velasco, M., additional, Mendiola Fernández, M.V., additional, Ruiz Genao, D., additional, Muñoz Santos, C., additional, García-Doval, I., additional, and Descalzo, M.A., additional

Published
2018
Full Text
View/download PDF

18. Description of Patients Treated with Biologic Drugs as First-Line Systemic Therapy in the BIOBADADERM Registry Between 2008 and 2016

Author

Carretero Hernández, G., primary, Ferrándiz, C., additional, Rivera Díaz, R., additional, Daudén Tello, E., additional, de la Cueva-Dobao, P., additional, Gómez-García, F.J., additional, Herrera-Ceballos, E., additional, Belinchón Romero, I., additional, López-Estebaranz, J.L., additional, Alsina Gibert, M., additional, Sánchez-Carazo, J.L., additional, Ferrán Farrés, M., additional, González Quesada, A., additional, Carrascosa Carrillo, J.M., additional, Llamas-Velasco, M., additional, Mendiola Fernández, M.V., additional, Ruiz Genao, D., additional, Muñoz Santos, C., additional, García-Doval, I., additional, and Descalzo, M.A., additional

Published
2018
Full Text
View/download PDF

22. Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm Registry

Author

Galiano Mejías, S., primary, Carretero, G., additional, Ferrandiz, C., additional, Vanaclocha, F., additional, Daudén, E., additional, Gómez-García, F.J., additional, Herrera-Ceballos, E., additional, Belinchón-Romero, I., additional, Sánchez-Carazo, J.L., additional, López-Estebaranz, J.L., additional, Alsina, M., additional, Ferrán, M., additional, Torrado, R., additional, Carrascosa, J.M., additional, Rivera, R., additional, Llamas-Velasco, M., additional, Jiménez-Puya, R., additional, Mendiola, Mª V., additional, Ruiz-Genao, D., additional, Descalzo, M.A., additional, and de la Cueva Dobao, P., additional

Published
2017
Full Text
View/download PDF

23. Manejo de los tratamientos biológicos en pacientes con psoriasis moderada-grave sometidos a intervenciones quirúrgicas en el registro español Biobadaderm

Author

Galiano Mejías, S., primary, Carretero, G., additional, Ferrandiz, C., additional, Vanaclocha, F., additional, Daudén, E., additional, Gómez-García, F.J., additional, Herrera-Ceballos, E., additional, Belinchón-Romero, I., additional, Sánchez-Carazo, J.L., additional, López-Estebaranz, J.L., additional, Alsina, M., additional, Ferrán, M., additional, Torrado, R., additional, Carrascosa, J.M., additional, Rivera, R., additional, Llamas-Velasco, M., additional, Jiménez-Puya, R., additional, Mendiola, Mª V., additional, Ruiz-Genao, D., additional, Descalzo, M.A., additional, and de la Cueva Dobao, P., additional

Published
2017
Full Text
View/download PDF

27. Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over time

Author

Carrascosa, J.M., primary, Rivera, N., additional, Garcia-Doval, I., additional, Carretero, G., additional, Vanaclocha, F., additional, Daudén, E., additional, Gómez-García, F.J., additional, De-la-Cueva-Dobao, P., additional, Herrera-Ceballos, E., additional, Belinchón, I., additional, Alsina, M., additional, Sánchez-Carazo, J.L., additional, Ferrán, M., additional, Lopez-Estebaranz, J.L., additional, Pérez-Zafrilla, B., additional, Llamas, M., additional, Rivera, R., additional, and Ferrándiz, C., additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results